Fangchinoline protects hepatic ischemia/reperfusion liver injury in rats through anti‐oxidative stress and anti‐inflammation properties: an in silico study
Biotechnology and Applied Biochemistry · 2024
DOI: 10.1002/bab.2628 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Applied Biochemistry, 2024. Verfasst von Shuangxi Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hepatopancreatobiliary Surgery Department, Second Affiliated Hospital of Kunming Medical University, Kunming, China. Hauptthemen laut MEDLINE: Reperfusion Injury, Oxidative Stress, Benzylisoquinolines, Liver. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: The authors extend their appreciation to the Researchers supporting Project number (RSP-2024R98), King Saud University, Riyadh, Saudi Arabia for financial supp….
Abstract (Originalsprache)
Liver ischemia‐reperfusion (I/R) injury is a common cause of organ failure, developed by a sudden block in the blood and oxygen supply and subsequent restoration. I/R damage is responsible for acute and chronic rejection after organ transplantation, accounting for 10% of early graft failure. The study investigated the therapeutic properties of fangchinoline in liver injury‐induced rats. The rats were divided into three groups: Sham, I/R without pretreatment, and I/R + 10 mg/kg fangchinoline pretreatment. Blood and liver samples were collected for assays, and an in silico docking analysis was conducted to determine fangchinoline's inhibitory effect. The pretreatment with 10 mg/kg of fangchinoline effectively reduced hepatic marker enzymes such as AST, LDH, and ALT in the serum of rats with liver I/R damage. Fangchinoline treatment significantly reduced interleukin‐8 (IL‐8), IL‐6, and tumor necrosis factor‐α (TNF‐α) in I/R‐induced rats, boosting antioxidants and decreasing MDA. Histopathological studies showed liver injury protection, and fangchinoline inhibited TNF‐α and IL‐6 with improved binding affinity. Fangchinoline has hepatoprotective properties by reducing inflammation in rats with liver I/R damage, as demonstrated in the current study. Hence, it can be an effective salutary agent in preventing liver damage caused by I/R.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hepatopancreatobiliary Surgery Department, Second Affiliated Hospital of Kunming Medical University, Kunming, China.
- Second Department of General Surgery, The Affiliated Hospital of Yunnan University, Kunming, China.
- Clinical Skills Training Center, Kunming Medical University, Kunming, Yunnan, China.
- Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia.
ORCID-Profile: Zehai Gao
Förderung
- The authors extend their appreciation to the Researchers supporting Project number (RSP-2024R98), King Saud University, Riyadh, Saudi Arabia for financial supp…
Zitieren
APA
Li, S., Xiang, A., Guo, F., Alarfaj, A. A., & Gao, Z. (2024). Fangchinoline protects hepatic ischemia/reperfusion liver injury in rats through anti‐oxidative stress and anti‐inflammation properties: an in silico study. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.2628
Vancouver
Li S, Xiang A, Guo F, Alarfaj AA, Gao Z. Fangchinoline protects hepatic ischemia/reperfusion liver injury in rats through anti‐oxidative stress and anti‐inflammation properties: an in silico study. Biotechnology and Applied Biochemistry. 2024. doi:10.1002/bab.2628
BibTeX
@article{Li2024,
author = {Li, Shuangxi and Xiang, AnDong and Guo, Feng and Alarfaj, Abdullah A and Gao, Zehai},
title = {Fangchinoline protects hepatic ischemia/reperfusion liver injury in rats through anti‐oxidative stress and anti‐inflammation properties: an in silico study},
journal = {Biotechnology and Applied Biochemistry},
year = {2024},
doi = {10.1002/bab.2628}
}
EUVIMED